AMPLY Discovery - Crunchbase Company Profile & Funding

Q: Who invested in AMPLY Discovery?

AMPLY Discovery has 12 investors including Keeps Biomed And Twin Path Ventures.

Q: When was the last funding round for AMPLY Discovery?

AMPLY Discovery closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has AMPLY Discovery raised to date?

AMPLY Discovery has raised obfuscated.

Overview

AMPLY Discovery

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About AMPLY Discovery

CB Rank

33163

AMPLY uses machine learning and synthetic biology to mine vast biological data to discover novel drug and nutraceutical candidates.

Founded

obfuscation

Private

Corporate Round

Belfast, Belfast, United Kingdom

1-10

amplydiscovery.com/

Artificial Intelligence (AI)

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Corporate Round

OBF

obfuscation

Seed

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Ben Thomas: Co-founder, CEO, and CTO
Oliver Rausch: Chief Scientific Officer
Past Role: Storm Therapeutics, Chief Scientific Officer

Details

Legal Name

AMPLY Discovery Ltd

Also Known As

AMPLY

Operating Status

Active

Company Type

For Profit

About the Company

AMPLY deploys machine learning and synthetic biology to mine vast biological data to discover novel drug and nutraceutical candidates. Using a proprietary in silico and in vitro platform we discover first-in-class molecules. AMPLY is helping tackle some of humankind's greatest challenges such as cancer, metabolic diseases, and MDR infections.

Contact Email

contact@amplydiscovery.com

Predictions & Insights

Growth Insight

See this Growth Insight

AMPLY Discovery is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

AMPLYfolio AI

A platform that analyzes diverse biological data using machine learning to identify novel drug candidates from natural sources.

Bioprinting and Compound Synthesis

A high-throughput process that converts digital biological discoveries into physical peptides, proteins, and RNAi molecules for testing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round
obfuscated obfuscation	Corporate Round - AMPLY Discovery	1	obfuscated obfuscation	Keeps Biomed	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Keeps Biomed	Yes	Corporate Round - AMPLY Discovery	—
Keeps Biomed	Yes	Corporate Round - AMPLY Discovery	—
Keeps Biomed	Yes	Corporate Round - AMPLY Discovery	—
Keeps Biomed	Yes	Corporate Round - AMPLY Discovery	—
Keeps Biomed	Yes	Corporate Round - AMPLY Discovery	—